Private Placement

Mezo is offering token rewards to lure over $11B in wrapped Bitcoin from Ethereum, aiming to build a native Bitcoin DeFi ecosystem and fulfill a long-held vision.

A new drill-free cavity treatment is regenerating teeth, attracting Wall Street, and aiming to solve a global health crisis. This is the story of Curodont™.

With new executive leadership, AI firm HealthLeap aims to accelerate its mission of improving patient outcomes and hospital finances nationwide.

As AI costs soar, Hammerspace gains industry validation for its dynamic data platform that maximizes GPU power while slashing cloud storage expenses.

A new 140-home luxury community in NC will integrate SKYX's NVIDIA AI-powered smart platform, signaling a new era for residential tech and real estate.

Oriental Culture Holding celebrates its 5th Nasdaq anniversary with a special dividend, but a look at its finances reveals a more complex picture.

Sweden secures sovereign satellite capabilities in a 9-figure deal, signaling a new era of European defense autonomy and disrupting the space industry.

Manas AI gains unique access to Schrödinger's physics platform, uniting top minds and tech to slash drug development timelines. Is this the future?

With a new board member and strategic investment, Kandu, Inc. is set to scale its brain-computer interface technology for stroke recovery.

Offerpad raises $18M in a direct offering. The move aims to bolster its finances and fund a strategic pivot to asset-light services in a changing market.

Tech consultancy Hylaine hires veteran exec Doug Hautop as President to lead an aggressive plan to scale, targeting Fortune 1000 enterprise clients.

Moderna CEO Stephane Bancel joins CFS's board, signaling a major push to commercialize fusion energy. Can his vaccine scale-up success crack the code?

Biomea Fusion launches a high-stakes 2026 plan, advancing a novel diabetes drug to restore insulin cells and an oral pill to rival obesity giants.

Interim data suggests LX2020 is well-tolerated and may reduce dangerous arrhythmias by targeting the root cause of PKP2-associated cardiomyopathy.

TriSalus Life Sciences reports record 53% annual revenue growth, but a closer look reveals a complex financial picture for the oncology innovator.

Adaptive posted a 55% revenue surge in 2025, fueled by its clonoSEQ cancer test. Now, the firm is charting a clear course to company-wide profitability.

Annexon is poised for a landmark year with potential first-in-class drugs for GBS and GA, promising to reset treatment standards and offer new hope.

Uniper secures 500,000 tons of certified green ammonia from India's AM Green, forging a new energy axis and fueling Europe's industrial decarbonization.

A minor change in Collective Metals' $1.5M financing deal reveals the high stakes in its hunt for Canadian uranium. Here’s what it means for investors.

Anzie Blue and Honda Powersports' NYE livestream on CNN showcased a diverse Music City, proving local venues can command a worldwide stage.